Early arthritis clinic is effective for rheumatoid and psoriatic arthritides View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2019-04

AUTHORS

M. K. Nisar

ABSTRACT

INTRODUCTION: Early arthritis clinics (EACs) have been well established since 1980s. Most of the data for their effectiveness comes from rheumatoid arthritis (RA) management and is largely limited to process outcomes. There is little evidence that such clinics improve clinical outcomes particularly for psoriatic arthritis (PsA). We examined whether EACs provide better outcomes irrespective of final arthritis diagnosis. METHODS: A 52-week prospective observational study of all inflammatory arthritis patients presenting to early arthritis service at our secondary care hospital in 2016 was undertaken. A protocolised approach to the early initiation of therapy (within 3 weeks) and 6-weekly review of treatment outcomes was embedded irrespective of the arthritis diagnosis. Statistical analysis was undertaken using Mann-Whitney U test for disease activity scores to ascertain the significance of outcomes. RESULTS: Of 1884 patients referred, 482 (25.5%) were triaged into EACs based on set criteria. 159 (64.3%) had RA, 55 (22%) with PsA and 33 had other inflammatory arthritides. Mean DAS28 for RA at first visit was 4.65 (0.6-8.0). Treating to target achieved DAS28 remission for 84 (53.5%) and low disease activity (LDA) for a further 44 (34%). Median time to achieve remission or LDA was 20 weeks (0-52 weeks). Mean tender (TJ) and swollen joint (SJ) counts for PsA at first visit were 8.2 (1-35) and 3.5 (0-14), respectively [n = 55]. The patient (PtGA) and physician (PhGA) global assessments mean were 3.0 and 2.9 (1-5). Target [TJ and SJ ≤ 2] was achieved for 38 patients (69%) and good PsARC response for a further four (7%). Median time to achieve the target or good response was 22 weeks (0-48 weeks). Final TJ and SJ mean was significantly better at 1.2 (0-4) and 0.3 (0-2) [p < 0.0001] with similar improvement in PtGA [mean 1.8 (1-4)] and PhGA [mean 1.6 (1-3)]. CONCLUSION: Dedicated EACs help achieve good clinical outcomes in majority of patients with RA and PsA. Nearly 80% of our cohort attained the target or good disease response in less than 6 months. This was despite a significant delay in patients presenting to their GPs and moderately high disease activity. More... »

PAGES

657-662

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s00296-019-04253-4

DOI

http://dx.doi.org/10.1007/s00296-019-04253-4

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1112225740

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/30783800


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "name": [
            "Rheumatology Department, Luton and Dunstable University Hospital NHSFT, Lewsey Road, LU4 0DZ, Luton, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Nisar", 
        "givenName": "M. K.", 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1002/acr.20682", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000842472"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1053/berh.2000.0122", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001299631"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/art.39573", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005700908"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1136/ard.2005.044354", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019034204"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/rheumatology/30.4.241", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021544985"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1136/annrheumdis-2015-208337", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022767391"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0002-9343(01)00872-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037837114"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/art.10092", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1041378333"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/1471-2474-14-101", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042827234", 
          "https://doi.org/10.1186/1471-2474-14-101"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1136/annrheumdis-2013-204858", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1049967398"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1077969758", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1078691041", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1079081538", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1136/annrheumdis-2016-210602", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1079378684"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.7861/clinmedicine.17-1-65", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1083403485"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2019-04", 
    "datePublishedReg": "2019-04-01", 
    "description": "INTRODUCTION: Early arthritis clinics (EACs) have been well established since 1980s. Most of the data for their effectiveness comes from rheumatoid arthritis (RA) management and is largely limited to process outcomes. There is little evidence that such clinics improve clinical outcomes particularly for psoriatic arthritis (PsA). We examined whether EACs provide better outcomes irrespective of final arthritis diagnosis.\nMETHODS: A 52-week prospective observational study of all inflammatory arthritis patients presenting to early arthritis service at our secondary care hospital in 2016 was undertaken. A protocolised approach to the early initiation of therapy (within 3\u00a0weeks) and 6-weekly review of treatment outcomes was embedded irrespective of the arthritis diagnosis. Statistical analysis was undertaken using Mann-Whitney U test for disease activity scores to ascertain the significance of outcomes.\nRESULTS: Of 1884 patients referred, 482 (25.5%) were triaged into EACs based on set criteria. 159 (64.3%) had RA, 55 (22%) with PsA and 33 had other inflammatory arthritides. Mean DAS28 for RA at first visit was 4.65 (0.6-8.0). Treating to target achieved DAS28 remission for 84 (53.5%) and low disease activity (LDA) for a further 44 (34%). Median time to achieve remission or LDA was 20\u00a0weeks (0-52\u00a0weeks). Mean tender (TJ) and swollen joint (SJ) counts for PsA at first visit were 8.2 (1-35) and 3.5 (0-14), respectively [n\u2009=\u200955]. The patient (PtGA) and physician (PhGA) global assessments mean were 3.0 and 2.9 (1-5). Target [TJ and SJ\u2009\u2264\u20092] was achieved for 38 patients (69%) and good PsARC response for a further four (7%). Median time to achieve the target or good response was 22\u00a0weeks (0-48\u00a0weeks). Final TJ and SJ mean was significantly better at 1.2 (0-4) and 0.3 (0-2) [p\u2009<\u20090.0001] with similar improvement in PtGA [mean 1.8 (1-4)] and PhGA [mean 1.6 (1-3)].\nCONCLUSION: Dedicated EACs help achieve good clinical outcomes in majority of patients with RA and PsA. Nearly 80% of our cohort attained the target or good disease response in less than 6\u00a0months. This was despite a significant delay in patients presenting to their GPs and moderately high disease activity.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/s00296-019-04253-4", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1093123", 
        "issn": [
          "0172-8172", 
          "1437-160X"
        ], 
        "name": "Rheumatology International", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "4", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "39"
      }
    ], 
    "name": "Early arthritis clinic is effective for rheumatoid and psoriatic arthritides", 
    "pagination": "657-662", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "725c8bbd40b74327b387efd2d2e3372a1728e04151be4facfd2258e88ffa57d5"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "30783800"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "8206885"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s00296-019-04253-4"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1112225740"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s00296-019-04253-4", 
      "https://app.dimensions.ai/details/publication/pub.1112225740"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T13:27", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000370_0000000370/records_46738_00000003.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://link.springer.com/10.1007%2Fs00296-019-04253-4"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00296-019-04253-4'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00296-019-04253-4'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00296-019-04253-4'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00296-019-04253-4'


 

This table displays all metadata directly associated to this object as RDF triples.

110 TRIPLES      21 PREDICATES      44 URIs      21 LITERALS      9 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s00296-019-04253-4 schema:about anzsrc-for:11
2 anzsrc-for:1103
3 schema:author N05768a2313634d6a9bbe9d3776f01ede
4 schema:citation sg:pub.10.1186/1471-2474-14-101
5 https://app.dimensions.ai/details/publication/pub.1077969758
6 https://app.dimensions.ai/details/publication/pub.1078691041
7 https://app.dimensions.ai/details/publication/pub.1079081538
8 https://doi.org/10.1002/acr.20682
9 https://doi.org/10.1002/art.10092
10 https://doi.org/10.1002/art.39573
11 https://doi.org/10.1016/s0002-9343(01)00872-5
12 https://doi.org/10.1053/berh.2000.0122
13 https://doi.org/10.1093/rheumatology/30.4.241
14 https://doi.org/10.1136/annrheumdis-2013-204858
15 https://doi.org/10.1136/annrheumdis-2015-208337
16 https://doi.org/10.1136/annrheumdis-2016-210602
17 https://doi.org/10.1136/ard.2005.044354
18 https://doi.org/10.7861/clinmedicine.17-1-65
19 schema:datePublished 2019-04
20 schema:datePublishedReg 2019-04-01
21 schema:description INTRODUCTION: Early arthritis clinics (EACs) have been well established since 1980s. Most of the data for their effectiveness comes from rheumatoid arthritis (RA) management and is largely limited to process outcomes. There is little evidence that such clinics improve clinical outcomes particularly for psoriatic arthritis (PsA). We examined whether EACs provide better outcomes irrespective of final arthritis diagnosis. METHODS: A 52-week prospective observational study of all inflammatory arthritis patients presenting to early arthritis service at our secondary care hospital in 2016 was undertaken. A protocolised approach to the early initiation of therapy (within 3 weeks) and 6-weekly review of treatment outcomes was embedded irrespective of the arthritis diagnosis. Statistical analysis was undertaken using Mann-Whitney U test for disease activity scores to ascertain the significance of outcomes. RESULTS: Of 1884 patients referred, 482 (25.5%) were triaged into EACs based on set criteria. 159 (64.3%) had RA, 55 (22%) with PsA and 33 had other inflammatory arthritides. Mean DAS28 for RA at first visit was 4.65 (0.6-8.0). Treating to target achieved DAS28 remission for 84 (53.5%) and low disease activity (LDA) for a further 44 (34%). Median time to achieve remission or LDA was 20 weeks (0-52 weeks). Mean tender (TJ) and swollen joint (SJ) counts for PsA at first visit were 8.2 (1-35) and 3.5 (0-14), respectively [n = 55]. The patient (PtGA) and physician (PhGA) global assessments mean were 3.0 and 2.9 (1-5). Target [TJ and SJ ≤ 2] was achieved for 38 patients (69%) and good PsARC response for a further four (7%). Median time to achieve the target or good response was 22 weeks (0-48 weeks). Final TJ and SJ mean was significantly better at 1.2 (0-4) and 0.3 (0-2) [p < 0.0001] with similar improvement in PtGA [mean 1.8 (1-4)] and PhGA [mean 1.6 (1-3)]. CONCLUSION: Dedicated EACs help achieve good clinical outcomes in majority of patients with RA and PsA. Nearly 80% of our cohort attained the target or good disease response in less than 6 months. This was despite a significant delay in patients presenting to their GPs and moderately high disease activity.
22 schema:genre research_article
23 schema:inLanguage en
24 schema:isAccessibleForFree false
25 schema:isPartOf N5e423e44e7854bca880d3ccf96cd1c28
26 Ne5abc3c3e2074f1f8fe4f7730e9096f2
27 sg:journal.1093123
28 schema:name Early arthritis clinic is effective for rheumatoid and psoriatic arthritides
29 schema:pagination 657-662
30 schema:productId N308633f563044df4be37068eee196747
31 N36959b097c5646c59e5516b4da123d86
32 N43c290ad1c06441681ac773f813d095b
33 N6bf90c762eb540de8f1c1772a90f8722
34 Nad98e8a4b26745c9aacbbbd4d1897188
35 schema:sameAs https://app.dimensions.ai/details/publication/pub.1112225740
36 https://doi.org/10.1007/s00296-019-04253-4
37 schema:sdDatePublished 2019-04-11T13:27
38 schema:sdLicense https://scigraph.springernature.com/explorer/license/
39 schema:sdPublisher N9df0143e74e0423093691ed499f38762
40 schema:url https://link.springer.com/10.1007%2Fs00296-019-04253-4
41 sgo:license sg:explorer/license/
42 sgo:sdDataset articles
43 rdf:type schema:ScholarlyArticle
44 N05768a2313634d6a9bbe9d3776f01ede rdf:first N526a2f004f184e7d83cef11a5def4a65
45 rdf:rest rdf:nil
46 N308633f563044df4be37068eee196747 schema:name doi
47 schema:value 10.1007/s00296-019-04253-4
48 rdf:type schema:PropertyValue
49 N36959b097c5646c59e5516b4da123d86 schema:name pubmed_id
50 schema:value 30783800
51 rdf:type schema:PropertyValue
52 N43c290ad1c06441681ac773f813d095b schema:name nlm_unique_id
53 schema:value 8206885
54 rdf:type schema:PropertyValue
55 N526a2f004f184e7d83cef11a5def4a65 schema:affiliation Nb325a6492a5f42bbb865bc9703a256d7
56 schema:familyName Nisar
57 schema:givenName M. K.
58 rdf:type schema:Person
59 N5e423e44e7854bca880d3ccf96cd1c28 schema:issueNumber 4
60 rdf:type schema:PublicationIssue
61 N6bf90c762eb540de8f1c1772a90f8722 schema:name dimensions_id
62 schema:value pub.1112225740
63 rdf:type schema:PropertyValue
64 N9df0143e74e0423093691ed499f38762 schema:name Springer Nature - SN SciGraph project
65 rdf:type schema:Organization
66 Nad98e8a4b26745c9aacbbbd4d1897188 schema:name readcube_id
67 schema:value 725c8bbd40b74327b387efd2d2e3372a1728e04151be4facfd2258e88ffa57d5
68 rdf:type schema:PropertyValue
69 Nb325a6492a5f42bbb865bc9703a256d7 schema:name Rheumatology Department, Luton and Dunstable University Hospital NHSFT, Lewsey Road, LU4 0DZ, Luton, UK
70 rdf:type schema:Organization
71 Ne5abc3c3e2074f1f8fe4f7730e9096f2 schema:volumeNumber 39
72 rdf:type schema:PublicationVolume
73 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
74 schema:name Medical and Health Sciences
75 rdf:type schema:DefinedTerm
76 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
77 schema:name Clinical Sciences
78 rdf:type schema:DefinedTerm
79 sg:journal.1093123 schema:issn 0172-8172
80 1437-160X
81 schema:name Rheumatology International
82 rdf:type schema:Periodical
83 sg:pub.10.1186/1471-2474-14-101 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042827234
84 https://doi.org/10.1186/1471-2474-14-101
85 rdf:type schema:CreativeWork
86 https://app.dimensions.ai/details/publication/pub.1077969758 schema:CreativeWork
87 https://app.dimensions.ai/details/publication/pub.1078691041 schema:CreativeWork
88 https://app.dimensions.ai/details/publication/pub.1079081538 schema:CreativeWork
89 https://doi.org/10.1002/acr.20682 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000842472
90 rdf:type schema:CreativeWork
91 https://doi.org/10.1002/art.10092 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041378333
92 rdf:type schema:CreativeWork
93 https://doi.org/10.1002/art.39573 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005700908
94 rdf:type schema:CreativeWork
95 https://doi.org/10.1016/s0002-9343(01)00872-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037837114
96 rdf:type schema:CreativeWork
97 https://doi.org/10.1053/berh.2000.0122 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001299631
98 rdf:type schema:CreativeWork
99 https://doi.org/10.1093/rheumatology/30.4.241 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021544985
100 rdf:type schema:CreativeWork
101 https://doi.org/10.1136/annrheumdis-2013-204858 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049967398
102 rdf:type schema:CreativeWork
103 https://doi.org/10.1136/annrheumdis-2015-208337 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022767391
104 rdf:type schema:CreativeWork
105 https://doi.org/10.1136/annrheumdis-2016-210602 schema:sameAs https://app.dimensions.ai/details/publication/pub.1079378684
106 rdf:type schema:CreativeWork
107 https://doi.org/10.1136/ard.2005.044354 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019034204
108 rdf:type schema:CreativeWork
109 https://doi.org/10.7861/clinmedicine.17-1-65 schema:sameAs https://app.dimensions.ai/details/publication/pub.1083403485
110 rdf:type schema:CreativeWork
 




Preview window. Press ESC to close (or click here)


...